The PIPgen Training Programme seeks to train the next generation of PI3K/PTEN experts and envisions to empower PI3K/PTEN related disease research in Europe towards clinical translation.
PIPgen stems from the emerging links between monogenic rare diseases and cancer. There are more than 7000 rare diseases, affecting approximately 30 million European Union citizens.
PIPgen brings together 9 leading European basic and clinical institutions and 3 private companies experts in the PI3K/PTEN field, to train 15 researchers at the Phd level in a wide range of scientific and complementary competences. The main goal of this H2020 funded project is to change the European biomedical landscape in PI3K/PTEN-related diseases.
We aim to train a unique cohort of creative and entrepreneurial ESRs in a wide range of scientific and complementary competences towards changing the European biomedical landscape in PI3K/PTEN-related diseases.